Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Robert E. Coleman, Andrew Hall, Joan Albanell, Andrew Hanby, Richard H. Bell, David Cameron, David Dodwell, Helen Marshall, Joël Jean-Mairet, Juan-Carlos Tercero,

The Lancet Oncology · 2017 · 76 citations · 12 references

DOIFull text

Open access

Concepts

References

12